Patent · US Active

Substances and methods for the use in prevention and/or treatment in Huntington's disease

US10053518B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignee

AFFIRIS AG · AT

Inventors

Oskar SMRZKA · Wien, AT
Stefan Bartl · Wien, AT
Michela Parth · Wien, AT

Key dates

Filing date	Jul 10, 2015
Grant date	Aug 21, 2018
Priority date	—
Expiry date	Jul 10, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2835
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is an apheresis device comprising a solid carrier capable of being contacted with the blood or plasma flow, characterised in that the solid carrier includes one or several HTT-binding molecule(s) capable of adsorbing HTT or fragments thereof in a specific manner from plasma or blood or other HTT containing body fluids such as CSF.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.